The European Federation for Exploratory Medicines Development – EUFEMED – was founded in 2015 as a result of an ongoing, informal collaboration between several European societies active in the area of human pharmacology.
EUFEMED has been recognized as a stakeholder by European Medicines Agency (EMA) and is consulted for the revision of important European regulations and guidelines related to clinical drug development.
EUFEMED is a not for profit association established under the Belgian law. In order to strengthen the voice of EUFEMED and in the importance of early medicines development in Europe, other national societies active in human pharmacology are invited to apply to become members. Institutions, pharma or service provider companies can apply for associate membership.
Upcoming events
25th – 26th May 2023 – 4th EUFEMED Conference: Mastering the New Time Pressure on Human Pharmacology
EUFEMED is delighted to announce our 4th Conference on 25th – 26th May 2023 Pre-workshop on May 24, 2023 Langenbeck-Virchow Haus Berlin Germany The Conference is entitled Mastering the New… Read More
About us
EUFEMED represents national and European federations, organisations or associations active in early clinical medicines development. You can find our Mission Statement here.
Based on the successful collaborations since 2007 between our members, their comparable objectives and the growing importance of early clinical drug development EUFEMED strives to be a ‘voice’ in the interest of exploratory medicines development in Europe.
EUFEMED promotes the interest of early clinical medicines development in professional organisations, international organisations and public authorities.
Our aims are to help the members in all professional fields, organise meetings and conferences, courses and specialist training, and much more… We develop standards and promote guidance documents in early medicines development in order to improve European competitiveness.
Read more about us here >
